Aktie A3CM04 TREACE MEDICAL CONCEPTS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Treace Medical Concepts, Inc.

Aktien

A3CM04

US89455T1097

TMCI

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 28.06.2024 		% 5 Tage % 1. Jan.
6,65 USD +0,15 % Intraday Chart für Treace Medical Concepts, Inc. +11,95 % -47,84 %
29.05. Treace Medical Concepts Insider kaufte Aktien im Wert von $253,475, laut einer aktuellen SEC Einreichung MT
16.05. TREACE MEDICAL CONCEPTS, INC. : UBS ist neutral ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from S&P Healthcare Equipment Select Industry Index
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing
Treace to Present at Truist Securities MedTech Conference
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
North American Morning Briefing : The "Everything -2-
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Top Midday Decliners
Top Premarket Decliners
Treace Medical Concepts Falls 57% Premarket After Revising 2024 Sales Outlook to $201-$211 Million From $220-$225 Million
Treace Medical Concepts: Q1 Earnings Snapshot
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q1 Revenue $51.1M, vs. Street Est of $49.1M
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Treace Medical Concepts Reports First Quarter 2024 Financial Results
Treace Medical Concepts, Inc. Revises Earnings Guidance for the Full-Year 2024
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
Treace to Present at Bank of America Health Care Conference
Treace Announces First Annual National Bunion Day
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CM04 Aktie
  4. Nachrichten Treace Medical Concepts, Inc.
  5. Andere Sprachen